Aside from TNF-α blockers, there have been five reports of the application of IL inhibitors in DCS subjects as the role of IL-17/IL-23 has been established in the pathogenesis of FOT diseases [65, 75]. The gene discussed is IL17A; the disease is Dorfman-Chanarin disease.